The scientist spoke about the status of participants in the test of the vaccine from COVID-19

“In general, the vaccine is well tolerated, and the condition does not cause any clinical concern,” RIA Novosti quoted him as saying.

Semitko added that at the end of the month the results of the first phase of the clinical trial will be ready.

Earlier, Russian Defense Minister Sergei Shoigu reported to Russian leader Vladimir Putin that studies of the vaccine against COVID-19 would be completed in late July.